SOURCE-LINKED STUDY SUMMARY
Oxymetholone-Associated Cholestatic Drug-Induced Liver Injury With Profound Hyperbilirubinaemia: A Longitudinal Case Report.
Abstract summarized · Quality not appraised
- Studied
- A case report of severe bile-flow-related liver injury after self-administered oxymetholone with testosterone enanthate.
- Who / model
- One 26-year-old man presented after 29 days of oral oxymetholone with intramuscular testosterone enanthate.
- Studied dose & schedule
- Dose and schedule have not yet been extracted for this summary.
- Found
- Peak total bilirubin reached 24.6 mg/dL while clotting, albumin and kidney function stayed preserved. After both agents were stopped, bilirubin fell 69.1% by day 57 and 91.5% by day 85, and itching resolved.
- Limits
- Concomitant testosterone and unverified products prevented definitive attribution to oxymetholone. This uncontrolled case also cannot show that supportive treatment caused recovery.
Read summary source ↗ · Prepared 9/15/2026 · AI-assisted, source-based summary
Research findings apply to the population and conditions studied. This educational summary is not a treatment recommendation or a formal assessment of study quality.
Original publication ↗ · DOI: 10.1155/crhe/2519455